Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27) - Image 1

£84.43

Springer Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Name: Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)
Brand: Springer
Price: 84.43 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£84 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 8 days • 8 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 8 days • 1 price levels

Days at Price

Price Analysis

Most common price: £84 (8 days, 100.0%)

Price range: £84 - £84

Price levels: 1 different prices over 8 days

Description

Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients. The material has biological activity by intravenous, intramus cular and subcutaneous routes. Clinical toxicity principally involves the 'influen za like' syndrome previously seen with native interferons. Other important toxi cities include anorexia, hepatitis, confusion and myelosuppression. Tolerable doses in multiple schedules and routes of administration have been determined. Phase II clinical trials with multiple routes and schedules of administration have been performed. Significant clinical activity has been found in non Hodgkin's lymphomas (both low grade and high grade), refractory and relapsing multiple myeloma, hairy cell leukemia, Kaposi's sarcoma, with suggestions of activity in Hodgkin's disease, renal cell carcinoma, and melanoma. The studies performed to date have for the most part involved small numbers of heavily pre-treated patients. Large-scale clinical trials in some of these disea ses are now warranted in populations of patients with as little bulk disease and prior treatment as is feasible for each tumour type. This is particularly the case in . Hodgkin's disease and subcategories of the non-Hodgkin's lymphomas. Alterna tely, interferon alpha-2 might be used to maintain remissions induced by other modalities (i. e. , in NHL, multiple myeloma, ovarian cancer). In some advanced disease settings, combinations of interferon alpha-2 with chemotherapeutic agents should now be investigated.

Key Features

Used Book in Good Condition

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0898387019
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 30 April 1985
Listed Since: 12 January 2007

Barcode

No barcode data available

Springer Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Interferon and Cancer

Interferon: The Science and Selling of a Miracle Drug (Routledge Studies in the History of Science, Technology and Medicine)

Immune Interferon: Properties and Clinical Applications (Pharmacology and Toxicology: Basic and Clinical Aspects)

Interferons: Characterization and Clinical Applications Book

Anti-Infective Applications of Interferon-Gamma

Viruses and Interferon: Current Research

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Bacterial Activation of Type I Interferons

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)

Infection and Cancer: Bi-Directorial Interactions

OSH Infection in the Immunocompromised Host (Oxford Specialist Handbooks)

Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation

Prognostic and Therapeutic Applications of RKIP in Cancer

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)

Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Humana Cancer Immunosurveillance: Methods and Protocols 1884